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reasoning (p=0.016) and visual memory (p=0.014). 
Within the NS/FS group there was a lower neurodevelopmental level 
in children with history of infantile spasms (p=0.026). 
Conclusions: Patients with nonsense or frameshift variants show a 
lower neurodevelopmental level; however, a history of infantile 
spasms modulates this genotype-phenotype relationship. 
Correspondence: Silvia Camara-Barrio, Hospital Niño Jesus, 
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Neocerebellar abnormalities in a neonate with the FOXP2 
mutation 
Georgios P.D. Argyropoulos, Rachael Elward, Maneet Saini, 
Mortimer Mishkin, Faraneh Vargha-Khadem 
Objective: A dominantly inherited verbal and orofacial dyspraxia in 
half the members of the multi-generational ‘KE family' is linked to a 
mutation in FOXP2, the first gene implicated in the developmental 
processes culminating in articulate speech and language. Neural and 
genetic substrates of this disorder may inform the ontogeny and 
developmental trajectory of human speech. Foxp2 expression is 
known to occur strikingly early during embryonic development and is 
prominent in the human, rodent and avian olivo- and ponto-cerebellar 
circuits. Indeed, imaging studies from our laboratory on affected KE 
family members aged 9-77 years have previously reported structural 
and functional abnormalities in the cerebellum as well as other 
cortical and subcortical structures. However, up to now, it had not 
been possible to document the emergence of FOXP2-dependent 
abnormalities in the brain of affected neonates from this large 
pedigree. 
Methods: We analysed structural T1- and T2-weighted magnetic 
resonance images acquired from a neonate with the FOXP2 
mutation, his unaffected twin, and 12 healthy control neonates (6-16 
weeks-old). We used voxel-based morphometry and volumetry to 
investigate grey- and white-matter abnormalities in the affected 
neonate. 
Results: We report a marked reduction of neocerebellar lobule VIIa 
Crus I in the affected member as compared to his unaffected sibling 
and unrelated controls. 
Conclusions: FOXP2 mutation is associated with cerebellar Crus I 
volume reduction from the early stages of neonatal life, consistent 
with the gene's expression in the human embryonic cerebellum. 
These findings highlight the significance of cerebellar abnormalities 
in developmental orofacial dyspraxia in the pre-linguistic infant. 
Correspondence: Georgios P.D.Argyropoulos, UCL Institute of 
Child Health, gargyropoulos@gmail.com 
 
Genetic subtyping and its implications for clinical management: 
The case of 22q11.2 syndrome 
Jos Egger, Willem Verhoeven, Joep Tuerlings, Nicole De Leeuw 
Objectives: The 22q11.2 deletion syndrome (22qDS), mostly caused 
by the common deletion (LCR-A-D) including TBX and COMT genes, 
is highly associated with congenital anomalies and endocrine 
dysfunctions accompanied by schizophrenia-like psychoses and 
autism spectrum disorders. The distal deletion (LCR-D-H) comprises 
the MAPK1 gene and is associated with specific heart defects and 
the presence of anxiety disorders. The relatively rare central deletion 
(LCR-B-D) encompasses the CRKL gene and predominantly shows 
renal/urogenital anomalies in combination with autistic-like 
behaviours. 
Participants and Methods: Thirty patients with genetically proven 
and subtyped 22q11DS were referred to the Dutch national 
outpatient facility specialized in psychopathology and genetics for 
detailed cognitive neuropsychiatric assessment in order to ascertain 
the most appropriate neuropsychological and psychopharmacological 
strategy. 
Results: Apart from one distal and one central deletion, common 
deletion was found in 28 patients. They presented with a variable 
level of intellectual disability. Patients with common deletion had a 
history of relapsing schizophrenia-like psychoses, partial or non-
responsive to conventional antipsychotics, and often accompanied by 
anxieties and mood instability. The patient with distal deletion 
displayed anxiety symptoms, whereas in the one with central 
deletion, autistic-like behaviour was present. Most patients with 
common deletion could effectively be treated with targeted contextual 
measures and clozapine or quetiapine, often combined with valproic 
acid. The patient with distal deletion showed full remission upon 
treatment with citalopram whereas in the patient with central deletion, 
behaviour strongly improved upon contextual-neuropsychological 
and behavioural measures only. 
Discussion: Clinical management of patients with 22q11DS should 
be guided primarily by its genetic subtype. 
Correspondence: Jos.Egger, Vincent van Gogh Institute for 
Psychiatry, j.egger@donders.ru.nl 
 
Intellectual development in Noonan syndrome: A longitudinal 
study 
Renée Roelofs, Nikki Janssen, Ellen Wingbermühle, Roy Kessels, 
Jos Egger 
Objective: While cognitive impairments in adults with Noonan 
syndrome (NS) seem to be limited to a low-average intelligence and 
slower processing speed, studies in children with NS have 
demonstrated more extensive cognitive problems (e.g. deficits in 
language, memory, attention, and executive functioning). This 
longitudinal study is the first to investigate intellectual development in 
patients with NS. Although childhood IQ is expected to be lower than 
adult IQ, it is assumed to be a significant predictor of adult 
intelligence. 
Participants and Methods: Sixteen patients with NS underwent 
intelligence assessment in childhood and in adulthood, using 
Wechsler's intelligence scales. IQ scores and Wechsler standard 
scores achieved in childhood and adulthood were compared. 
Childhood verbal and performance IQ (VIQ/PIQ) were included as 
predictors in multiple regression analyses for adult IQ and index 
scores. 
Results: Compared with childhood scores, adult full-scale IQ (FSIQ) 
and PIQ significantly increased (FSIQ: t(15)= 2.88, p= .01, η2= .36; 
PIQ: t(15)= 5.49, p< .001, η2= .67). Adult PIQ was higher than VIQ 
(t(15)= -2.23, p= .04, η2= .25). Childhood PIQ and VIQ together 
predicted all adult IQ and index scores (adjusted R2> .62, F> 13.32, 
p<.001), except for processing speed. 
Conclusions: In accordance with the hypothesis, childhood IQ 
significantly predicted adult intelligence in patients with NS. PIQ 
advanced to a normal level in adulthood, while VIQ did not develop 
proportionately, resulting in a discrepancy between adult PIQ and 
VIQ. This may suggest a delay in the development of executive 
functioning in patients with NS, which seems to be outgrown in 
adulthood. 
Correspondence: Renée Roelofs, Vincent van Gogh Institute for 
Psychiatry, rroelofs@vvgi.nl 
 
Quality of life in adults with Noonan syndrome 
Ellen Wingbermühle, Floor Nobbe, Renée Roelofs, Ineke Van der 
Burgt, Roy Kessels, Jos Egger 
Objective: Noonan syndrome (NS) is a genetic disorder related to 
mutations in the RAS-MAPK pathway. Cardinal features include short 
stature, facial dysmorphia, congenital heart defects, subtle cognitive 
decrements and a slightly lowered mean IQ (≈ 90). These 
characteristics may bring about lowered levels of quality of life (QoL). 
In this study, QoL was evaluated in adults with NS. 
Participants and Methods: Forty-five adult patients with NS and 26 
IQ-matched, healthy controls completed the Dutch version of the 
Lancashire Quality of Life Profile (LQoLP), a comprehensive 
structured interview covering nine domains of QoL, as well as global 
measures on wellbeing. Groups were compared using ANOVA and 
chi-square tests. 
Results: Patients with NS demonstrated significantly lower levels of 
QoL on two out of four general outcome measures (Happiness with 
life and Cantril’s ladder, p<0.05). Contrary to the controls, the 
majority of patients did not have a relationship (p<0.05). A history of 
being bullied in youth was more prevalent in the NS group (p<0.01,) 
and patients presented with significantly lower levels of self-esteem 
(p<0.05). No difference was found in satisfaction with health, in spite 
of the medical burden in the NS group. 
Conclusions: The QoL profile of adult NS patients differs from that 
of controls with respect to both subjective measures, such as 
happiness with life and self-esteem, and objective measures like 
relationship status. Lowered QoL in NS may be moderated by 
neurocognitive deficit, such as slower speed of information 
processing and alexithymic traits, which have been demonstrated in 
this group before. 
Correspondence: Ellen Wingbermuhle, Vincent van Gogh Institute 
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